September 20, 2007
Hologic snaps up west coast co.
By Matthew L. Brown
Hologic Inc., the Bedford medical imaging systems maker that is expected to acquire Marlborough-based Cytyc next month, announced today that it had completed the $70 million acquisition of BioLucent Inc. of Aliso Viejo, Calif.
Hologic paid for BioLucent with $65 million in company common stock and $5 million in cash. BioLucent makes the MammoPad breast cushion, which is intended to decrease discomfort during mammograms.
The acquisition furthers Hologic's efforts to offer a full portfolio of breast cancer detection and women's health products.
Hologic stockholders are scheduled to vote on the proposed $6.2 billion acquisition of Cytyc oct. 18. Cytyc makes breast cancer screening equipment.
Hologic paid for BioLucent with $65 million in company common stock and $5 million in cash. BioLucent makes the MammoPad breast cushion, which is intended to decrease discomfort during mammograms.
The acquisition furthers Hologic's efforts to offer a full portfolio of breast cancer detection and women's health products.
Hologic stockholders are scheduled to vote on the proposed $6.2 billion acquisition of Cytyc oct. 18. Cytyc makes breast cancer screening equipment.
WBJ Web Partners
Most Recent
Most Recent
0 Comments